VT
JAZZ icon

Vise Technologies’s Jazz Pharmaceuticals JAZZ Stock Holding History

Vise Technologies’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$560K Buy
+2,325
New +$509K 0.01% 1089

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Vise Technologies's JAZZ Position: Q2 2026 in Review

Vise Technologies opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 2,325 shares worth $560K. The stake represents 0.01% of the portfolio and ranks #1089 among its holdings.

641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Vise Technologies held 2,325 shares of Jazz Pharmaceuticals worth $560K as of Q2 2026.
  • Jazz Pharmaceuticals was a new Vise Technologies position in Q2 2026.
  • Jazz Pharmaceuticals made up 0.01% of Vise Technologies's portfolio in Q2 2026, its #1089 holding.
  • 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.